Fen Ning
Impact in
- Obstetrics and Gynecology top 5%
- Pregnancy and preeclampsia studies
- Immunology top 10%
- Reproductive System and Pregnancy
- Immune cells in cancer
Papers in
-
- Pregnancy and preeclampsia studies 10
- Immunology 16
- Reproductive System and Pregnancy 10
- Immunotherapy and Immune Responses 2
- Co-authors
- Gendie E. LashHuishu LiuGe ZhangShaohui CaiJun DuHaifang WangHao WangZongcai Liu
- Journals
- Placenta (4 papers)Molecular Human Reproduction (2 papers)Scientific Reports (1 paper)Cancer Research and Treatment (1 paper)Journal of Reproductive Immunology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fen Ning
30 papers receiving 851 citations
Peers
Comparison fields: 5 of 95
- Obstetrics and Gynecology 192
- Immunology 349
- Reproductive Medicine 74
- Oncology 231
- Cancer Research 122
Countries citing papers authored by Fen Ning
This map shows the geographic impact of Fen Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen Ning more than expected).
Fields of papers citing papers by Fen Ning
This network shows the impact of papers produced by Fen Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen Ning. The network helps show where Fen Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Fen Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 14 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 41 | |
| 11 | 2020 | 5 | |
| 12 | 2019 | 7 | |
| 13 | 2017 | 3 | |
| 14 | 2017 | 38 | |
| 15 | 2016 | 88 | |
| 16 | 2016 | 62 | |
| 17 | 2016 | 26 | |
| 18 | 2015 | 12 | |
| 19 | 2013 | 117 | |
| 20 | 2012 | 36 |
About Fen Ning
Fen Ning is a scholar working on Obstetrics and Gynecology, Immunology, Transplantation, Immunology and Allergy and Oncology, having authored 31 papers that have together received 858 indexed citations. Recurring topics across this work include Pregnancy and preeclampsia studies (10 papers), Reproductive System and Pregnancy (10 papers), Cancer Cells and Metastasis (5 papers), Fibroblast Growth Factor Research (2 papers), Immunotherapy and Immune Responses (2 papers), Transplantation: Methods and Outcomes (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Organ Transplantation Techniques and Outcomes (2 papers). The work is most often cited by research in Obstetrics and Gynecology (192 citations), Immunology (349 citations), Reproductive Medicine (74 citations), Oncology (231 citations) and Cancer Research (122 citations). Fen Ning has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Gendie E. Lash, Huishu Liu, Ge Zhang, Shaohui Cai, Jun Du, Haifang Wang, Hao Wang, Zongcai Liu, Hongsheng Wang and Haifang Wang. Their work appears in journals such as Placenta, Molecular Human Reproduction, Scientific Reports, Cancer Research and Treatment and Journal of Reproductive Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.